Literature DB >> 22339145

A qualitative study of obstacles to diaphragm and condom use in an HIV prevention trial in sub-Saharan Africa.

Deborah Kacanek1, Amanda Dennis, Nuriye Nalan Sahin-Hodoglugil, Elizabeth T Montgomery, Neetha Morar, Sibongile Mtetwa, Busi Nkala, Jessica Phillip, Connie Watadzaushe, Ariane van der Straten.   

Abstract

Consistent condom use and the substitution of condoms with potential HIV prevention methods of lower or unknown effectiveness are important concerns in the development of new prevention technologies. This qualitative study explored obstacles to consistent condom use with the diaphragm in MIRA, an HIV prevention trial in South Africa and Zimbabwe. We conducted 26 focus group discussions (FGDs) with 206 women and 7 FGDs and 10 in-depth interviews with 41 male partners of intervention-arm women. The belief that the diaphragm/gel prevented HIV, women's difficulties negotiating condom use, and men's unawareness that using the products together was recommended were obstacles to consistent condom use with the diaphragm/gel. Concerns about protection from HIV and pregnancy, recognition that the diaphragm was not yet proven to prevent HIV or sexually transmitted infections, and the trial context were facilitators. Understanding selective study product use in HIV prevention trials may inform improved adherence counseling and male involvement strategies.

Entities:  

Mesh:

Year:  2012        PMID: 22339145     DOI: 10.1521/aeap.2012.24.1.54

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  7 in total

1.  Improving men's participation in preventing mother-to-child transmission of HIV as a maternal, neonatal, and child health priority in South Africa.

Authors:  Wessel van den Berg; Kirsty Brittain; Gareth Mercer; Dean Peacock; Kathryn Stinson; Hanna Janson; Vuyiseka Dubula
Journal:  PLoS Med       Date:  2015-04-07       Impact factor: 11.069

Review 2.  Motivations and barriers to uptake and use of female-initiated, biomedical HIV prevention products in sub-Saharan Africa: an adapted meta-ethnography.

Authors:  Robyn Eakle; Adam Bourne; Caitlin Jarrett; Jonathan Stadler; Heidi Larson
Journal:  BMC Public Health       Date:  2017-12-19       Impact factor: 3.295

3.  Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa.

Authors:  Alexandra M Minnis; Sarah T Roberts; Kawango Agot; Rachel Weinrib; Khatija Ahmed; Kgahlisho Manenzhe; Fredrick Owino; Ariane van der Straten
Journal:  AIDS Behav       Date:  2018-08

Review 4.  Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale-up: a synthesis of evidence from sub-Saharan Africa.

Authors:  Robyn Eakle; Peter Weatherburn; Adam Bourne
Journal:  J Int AIDS Soc       Date:  2019-07       Impact factor: 5.396

5.  Acceptability and feasibility of the CHARISMA counseling intervention to support women's use of pre-exposure prophylaxis: results of a pilot study.

Authors:  Ellen K Wilson; L Danielle Wagner; Thesla Palanee-Phillips; Sarah T Roberts; Elizabeth E Tolley; Florence Mathebula; Laura Pascoe; Michele Lanham; Rose Wilcher; Elizabeth T Montgomery
Journal:  BMC Womens Health       Date:  2021-03-25       Impact factor: 2.809

Review 6.  Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.

Authors:  Elizabeth G Doggett; Michele Lanham; Rose Wilcher; Mitzy Gafos; Quarraisha A Karim; Lori Heise
Journal:  J Int AIDS Soc       Date:  2015-12-21       Impact factor: 5.396

7.  Risk perception and the influence on uptake and use of biomedical prevention interventions for HIV in sub-Saharan Africa: A systematic literature review.

Authors:  Emily A Warren; Pauline Paterson; William S Schulz; Shelley Lees; Robyn Eakle; Jonathan Stadler; Heidi J Larson
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.